New York obtains student loan debt relief fraud settlements
By Jonathan Stempel
NEW YORK (Reuters) – New York state’s attorney general said on Friday she has settled a lawsuit against three companies accused of tricking struggling borrowers into paying more than $1,000 for student loan debt relief services that were available for free.
Attorney General Letitia James said the accord permanently bans Debt Resolve Inc, Progress Advocates LLC, Student Loan Care LLC and two of the companies’ executives, Bruce Bellmare and Stanley Freimuth, from the debt relief industry.
James said the companies also agreed to excuse outstanding consumer loans and accept a $5.5 million court judgment, but will pay just $250,000 to satisfy it because they are in bankruptcy and have a limited ability to pay.
The defendants did not admit or deny wrongdoing. Their lawyer, Eric Krejci, said in an email: “Our clients believe they had valid defenses to this lawsuit, but a compromise was made to amicably settle.”
The settlement requires court approval.
In the lawsuit, James accused 13 defendants of fraud and violating consumer protection laws, through such practices as promising loan forgiveness they could not deliver, and charging illegal upfront fees and excessive interest rates.
The lawsuit began in September 2018 under James’ predecessor, Barbara Underwood. Twelve defendants have settled, resulting in $525,000 in restitution to consumers and more than $4 million in loan forbearance. The 13th defendant defaulted.
Student loan debt outstanding in the United States totaled about $1.68 trillion in March, according to the Federal Reserve.
(Reporting by Jonathan Stempel in New York; Editing by Richard Chang and Jonathan Oatis)
More Top Stories
U.S. President Donald Trump was scheduled to meet with his top law enforcement officer behind closed doors on Monday as cities nationwide awoke from a …read more
New York Governor Andrew Cuomo on Monday called for a national ban on chokeholds and excessive force by police and said he was concerned violent …read more
Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of …read more
With cities across the United States in turmoil over the death of George Floyd, a U.S. lawmaker plans to introduce legislation this week to eliminate …read more
An active duty military police battalion consisting of 200 to 250 military personnel is now in the process of deploying to Washington, DCread more